Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial

Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double‐blind placebo‐controlled crossover trial

Abstract Objective To assess whether the antiseizure medication levetiracetam may improve cognition in individuals with Alzheimer's disease who have not previously experienced a seizure. Methods We performed a randomized, double‐blind, placebo‐controlled crossover pilot study in individuals wit...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Arjune Sen, Sofia Toniolo, Xin You Tai, Mary Akinola, Mkael Symmonds, Sergio Mura, Joanne Galloway, Angela Hallam, Jane Y. C. Chan, Ivan Koychev, Chris Butler, John Geddes, Gabriel Davis Jones, Younes Tabi, Raquel Maio, Eleni Frangou, Sharon Love, Sian Thompson, Rohan Van Der Putt, Sanjay G. Manohar, Rupert McShane, Masud Husain
פורמט: Article
שפה:English
יצא לאור: Wiley 2024-12-01
סדרה:Epilepsia Open
נושאים:
antiseizure medications
dementia
epilepsy
Oxford Memory Test
seizure
גישה מקוונת:https://doi.org/10.1002/epi4.13070

אינטרנט

https://doi.org/10.1002/epi4.13070

פריטים דומים